相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synthesis and Anticancer Activity of Indolin-2-one Derivatives Bearing the 4-Thiazolidinone Moiety
Shuobing Wang et al.
ARCHIV DER PHARMAZIE (2012)
Synthesis and Cytotoxicity Studies of Novel 2-Hydrazonylpyrido[2,3-b]pyrazin-3(4H)-ones
Guogang Zhang et al.
ARCHIV DER PHARMAZIE (2012)
Inhibition of tumor cell growth, proliferation and migration by X-387, a novel active-site inhibitor of mTOR
Si-meng Chen et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Novel bis(indolyl)hydrazide-hydrazones as potent cytotoxic agents
Dalip Kumar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase Inhibitor
Sauveur-Michel Maira et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Cytotoxic and anti-inflammatory cembranoids from the Vietnamese soft coral Lobophytum laevigatum
Tran Hong Quang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Synthesis and biological evaluation of substituted 4-arylthiazol-2-amino derivatives as potent growth inhibitors of replicating Mycobacterium tuberculosis H37RV
Kuldeep K. Roy et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Synthesis and in-vitro anticancer activity of 3,5-bis(indolyl)-1,2,4-thiadiazoles
Dalip Kumar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Quantitative Structure Activity Relationship Study of 2,4,6-Trisubstituted-s-triazine Derivatives as Antimalarial Inhibitors of Plasmodium Falciparum Dihydrofolate Reductase
Himanshu Ojha et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2011)
Antitumor Efficacy of PKI-587, a Highly Potent Dual PI3K/mTOR Kinase Inhibitor
Robert Mallon et al.
CLINICAL CANCER RESEARCH (2011)
Analogues and Derivatives of Oncrasin-1, a Novel Inhibitor of the C-Terminal Domain of RNA Polymerase II and Their Antitumor Activities
Shuhong Wu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer
Matthew T. Burger et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor identified using the JFCR39 drug discovery system
De-xin Kong et al.
ACTA PHARMACOLOGICA SINICA (2010)
PKI-179: An orally efficacious dual phosphatidylinositol-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitor
Aranapakam M. Venkatesan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Visible and near-infrared sensing of fluoride by indole conjugated urea/thiourea ligands
Purnandhu Bose et al.
CHEMICAL COMMUNICATIONS (2010)
Vertical Targeting of the Phosphatidylinositol-3 Kinase Pathway as a Strategy for Treating Melanoma
Saadia A. Aziz et al.
CLINICAL CANCER RESEARCH (2010)
Pharmacophore identification and bioactivity prediction for triaminotriazine derivatives by electron conformational-genetic algorithm QSAR method
Emin Saripinar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Synthesis of aryl phosphates based on pyrimidine and triazine scaffolds
Caroline Courme et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Discovery of new 1,3,5-triazine scaffolds with potent activity against Mycobacterium tuberculosis H37Rv
Naresh Sunduru et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Bis(morpholino-1,3,5-triazine) Derivatives: Potent Adenosine 5′-Triphosphate Competitive Phosphatidylinositol-3-kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of Compound 26 (PKI-587), a Highly Efficacious Dual Inhibitor
Aranapakam M. Venkatesan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Identification and optimisation of novel and selective small molecular weight kinase inhibitors of mTOR
Keith A. Menear et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Evaluation of New Indole and Bromoindole Derivatives as pp60c-Src Tyrosine Kinase Inhibitors
Zuehal Kilic et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines
Naresh Sunduru et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1)
Wei Guo et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Quantitative structure-activity relationship modeling of triaminotriazine drugs based on Heuristic Method
Kunping Liu et al.
QSAR & COMBINATORIAL SCIENCE (2008)
ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol 3 kinase isoforms
Dexin Kong et al.
CANCER SCIENCE (2007)
Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives
Mingfang Zheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Synthesis of 2,4,6-trisubstituted pyrimidine and triazine heterocycles as antileishmanial agents
Naresh Sunduru et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives
F. Saczewski et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2006)
Antitumor activity of ZSTK474, a new phosphatidylitiositol 3-kinase inhibitor
Shin-ichi Yaguchi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Synthesis of 4-pyrido-6-aryl-2-substituted amino pyrimidines as a new class of antimalarial agents
A Agarwal et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Syntheses of 2,4,6-trisubstituted triazines as antimalarial agents
A Agarwal et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Molecular targets and anticancer potential of indole-3-carbinol and its derivatives
BB Aggarwal et al.
CELL CYCLE (2005)
分享论文
